Nuance Communications, Inc. (NUAN)
| Previous close | 55.99 |
| Open | 55.99 |
| Bid | 0.00 x 42300 |
| Ask | 0.00 x 321800 |
| Day's range | 55.98 - 56.00 |
| 52-week range | 40.75 - 56.00 |
| Volume | |
| Avg. volume | 5,693,606 |
| Market cap | 17.882B |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.33 |
| Earnings date | 04 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Bloomberg
Microsoft Vaults Further Into Health-Care Services With Closing of Nuance Deal
(Bloomberg) -- Microsoft Corp. completed its acquisition of Nuance Communications Inc., pushing the software giant deeper into the market for health-care services and artificial intelligence.Most Read from BloombergChina Warns U.S. Over Forming Pacific NATO, Backing TaiwanUkraine Open to Russia's Neutrality Demand But Won’t Yield Territory, Aide SaysOwners Fear Planes ‘Are Gone Forever’ After Russia Shields Them From SeizureChina Pushes Conspiracy Theory About U.S. Labs in UkraineUkraine Update:
- Bloomberg
IBM Sells Some Watson Health Assets for More Than $1 Billion
(Bloomberg) -- International Business Machines Corp. agreed to sell part of its IBM Watson Health business to private equity firm Francisco Partners, scaling back the technology company’s once-lofty ambitions in health care. Most Read from BloombergA Nor’easter Approaching New York Risks Becoming a Bomb CycloneMark Zuckerberg’s Stablecoin Ambitions Unravel With Diem Sale TalksStocks Drop, Yields Jump on Hawkish Powell Signals: Markets WrapAstronomers Spot Never-Before Seen Object at 4,000 Light-
- Bloomberg
Microsoft’s Activision Deal Set to Test Biden’s Antitrust Regime
(Bloomberg) -- Less than three weeks into 2022, President Joe Biden’s antitrust regime is facing its first big test of the year. Microsoft Corp.’s $69 billion all-cash takeover of Activision Blizzard Inc. brings together two major gaming platforms in a deal that directly affects consumers -- and could also raise grievances among some of the tech giant’s biggest rivals.Most Read from BloombergEarly Omicron Breakthroughs Show mRNA Vaccines’ WeaknessLate Rout in Tech Sends Nasdaq 100 Into Correctio
